Patrick Blain

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

BioVision, Inc. manufactures pharmaceutical products for apoptosis and cell signaling. It offers assay kits, antibodies, and recombinant proteins and enzymes. The company is headquartered in Milpitas, CA.

Zentiva Group as develops, manufactures and markets pharmaceuticals. Its products include generics for the treatment of cardiovascular, central nervous, and blood diseases, as well as anti-inflammatory drugs. The company was founded in 1933 and is headquartered in Prague, Czech Republic.

Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France.

Equitis Gestion SAS is an independent private equity service and investment management firm established in 2000 and located in Paris. Equitis manages private equity funds including venture capital and regional funds. The firm also manages private equity funds and portfolios for third parties, typically for large financial groups. Equitis provides a range of services to private equity investors, including company valuation, business plan audit, and secondary sale organization. Their clients are financial institutions, family trusts and corporations in France and abroad.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA.

Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France.

MAPI Développement SAS engages in conceiving and implementing studies to evaluate drugs. It provides research and clinical trial services, risk management plan, direct patient management, signal detection, strategic consulting and linguistic validation. The company was founded by Bernard Jambon in 1974 and is headquartered in Lyon, France.

Diverchim SA provides pharmaceutical services. It offers computer aided drug, medicinal chemistry, immunochemistry, chemical development, analytical services, and discovery. The firm products are building blocks and screening, collection, and new tools for asymmetric catalysis. The company was founded by Jean Louis Brayer and Benoit Folleas in March 2001 and is headquartered in Roissy-en-France, France.

Aventis Intercontinental SAS manufactures and distributes pharmaceutical products. The company was founded on December 22, 1988 and is headquartered in Antony, France.

Watchfrog SA creates and markets solutions for the in vivo detection of chemical, pharmaceutical and cosmetic substances. The firm offers to incorporate in vivo significance to early in vitro stage of drug discovery. It also offers biotechnological tools to accelerate environmental risk assessment. The company was founded by Barbara Demeneix and Gregory Lemkine in 2005 and is headquartered in Evry, France.

Meiogenix SAS operates as a biotech company which develops breeding technologies. Its technology allows the modulation of the homologous recombination in eukaryotic cells. It facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties. The company was founded by Giacomo Bastianelli and Alain Nicolas in 2011 and is headquartered in Paris, France.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Euromedical Instruments SARL distributes surgical radio-guided detection probes to surgeons and nuclear physicians. It comprises Europrobe3 read-out module which is fitted with a wide range of probes in order to address different clinical needs. The company was founded in 2000 and is headquartered in Paris, France.

Delpharm SAS develops and manufactures drugs. The company is headquartered in Issy-les-Moulineaux, France.

ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France.

Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019.

Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France.

Société de Chimie Thérapeutique is a French Medchem Society based in Malabry, France. The society is administered by an Executive Board and provides for the re-election or replacement of its members through a call for nominations process. The society also supports young researchers by providing a prestigious prize entitled “Prix d’Encouragement à la Recherche en Chimie Thérapeutique” sponsored by Institut de Recherche Servier, which is devoted to junior European scientists. The society complies with the law of July 10, 2012, on various provisions relating to electronic communications and transposes the European Directive No. 2009/136/EC of the European Parliament and of the Council of November 25, 2009, regarding the new constraints and obligations of publishers and owners of websites on information. The call for 2023 Young Medicinal Chemist in Industry Award is now closed, and the new call will be announced in November 2023.